Research

Research Outcomes: Building Hope

by St. Baldrick's Foundation
November 15, 2022

This research is powered by you. This quarterly edition of the St. Baldrick’s Foundation Research Outcomes recognizes promising research to improve survival rates, provide holistic therapies, and translate adult drugs into pediatric trials.

Thank you for making research possible.

Lab equipment with text Research Outcomes

Read more »


Research

Research Outcomes: Your Dollars at Work

by St. Baldrick's Foundation
August 8, 2022

Read on to learn about some of the research that – thanks to you – is changing the world of childhood cancer care.

lab equipment with text Research Outcomes

Read more »


Research

Research Outcomes: Incredible Impact and Hope

by St. Baldrick's Foundation
May 13, 2022

Formerly known as the St. Baldrick’s – Stand Up to Cancer Pediatric Cancer Dream Team, this team is now the St. Baldrick’s EPICC Team (Empowering Pediatric Immunotherapies for Childhood Cancer).

Your generosity makes a difference for children and young adults with cancer. Read on to see a few recent examples of the incredible impact you have on pediatric cancer research.

image of lab equipment with text Research Outcomes

Read more »


Research

St. Baldrick’s and the Children’s Oncology Group: An Ambitious Relationship

by St. Baldrick's Foundation
October 11, 2021

Did you know: The St. Baldrick’s Foundation and Children’s Oncology Group have been partners in the fight against childhood cancer since our founding.

graphic of St Baldrick’s and COG logos

Read more »


Research

Dramatic Progress for Medulloblastoma Patients

by St. Baldrick's Foundation
August 2, 2021

Want to know how St. Baldrick’s donors are the saving lives of kids with a common brain tumor? This isn’t just an example of progress – it’s the biggest increase in survival rates many researchers have ever seen from one clinical trial! And that trial was supported by St. Baldrick’s.


Grace was diagnosed with medullobalstoma at age 5. She is an almost-14-year survivor.

Read more »